The Future of You: Exploring the Complex World of Cryopreservation
The idea of pausing life, of cheating death, has captivated humanity for centuries. Today, that aspiration is being pursued through cryopreservation, also known as cryonics – the process of preserving a legally dead person at highly low temperatures, with the hope that future technology might revive them. But as the field advances, and companies like Tomorrow Bio emerge, a complex web of scientific, philosophical, and financial questions arises.
The Rising Costs and Logistics of “Biostasis”
Cryopreservation isn’t cheap. Alcor currently charges $80,000 for brain storage and $220,000 for whole-body preservation. Tomorrow Bio’s costs are comparable. Many individuals plan for these expenses through life insurance policies. The logistical challenges are significant. As Emil Kendziorra, CEO of Tomorrow Bio, notes, human cryopreservation is largely a logistical problem – responding quickly to deaths anywhere in the world is crucial. Tomorrow Bio initially focused on European sign-ups to streamline response times, but has recently expanded to accept members in the US, whereas still providing global coverage once signed up.
Is Revival Even Possible? The Scientific Hurdle
Despite advancements, the biggest obstacle remains the lack of a proven method for reanimation. Individuals like Robert Bedford, cryopreserved over 50 years ago, and Ted Coles, for over a decade, remain in storage. Scientists acknowledge the likelihood of successful revival is extremely low. However, for some, even a minuscule chance is enough. Nick Llewellyn, Director of Research and Development at Alcor, has signed up for brain preservation himself, driven by scientific curiosity about the future.
Beyond the Science: Philosophical and Societal Implications
The possibility of revival isn’t universally embraced within the scientific community. Shannon Tessier, a cryobiologist at Massachusetts General Hospital, questions the desirability of being revived centuries later, in a vastly different world, separated from loved ones. She highlights the complex philosophical, societal, and legal complications that would accompany such a scenario.
Tomorrow Bio’s Focus: Improving Preservation Quality
Tomorrow Bio is actively focused on improving preservation quality, recognizing that the threshold for successful revival remains unknown. Their 2026 plan centers on logistical improvements and refining preservation techniques. They publish annual quality data and maintain a two-tiered system in Europe – standby and pre-deploy-and-fly – to ensure rapid response times.
The Role of Entrepreneurs in Longevity Science
Emil Kendziorra’s journey exemplifies the growing intersection of entrepreneurship and longevity science. After initial research in cancer, he pivoted to entrepreneurship, recognizing the slow pace of progress in life-extension research. He previously founded and sold two companies before dedicating himself to Tomorrow Bio, viewing it as his life’s work. His background includes a medical degree from the University of Göttingen and prior membership at Alcor.
The Cryonics Community and Conferences
Kendziorra has been a key figure in fostering the cryonics community, hosting conferences like Biostasis2020, Biostasis2021, and Biostasis2022. He is also a signatory of the Scientists’ Open Letter on Cryonics, demonstrating a commitment to open discussion and scientific rigor within the field.
Did you understand?
Emil Kendziorra was initially signed up for cryopreservation at Alcor before realizing the need for a European-based organization focused on advancing the field.
FAQ
Q: What is biostasis?
A: Biostasis is another term for cryopreservation, the process of preserving a legally dead person at very low temperatures.
Q: How much does cryopreservation cost?
A: Costs vary, but Alcor charges $80,000 for brain storage and $220,000 for whole-body preservation. Tomorrow Bio’s charges are similar.
Q: Is there any guarantee of revival?
A: No, there is currently no proven method for reviving cryopreserved individuals.
Q: What is Tomorrow Bio’s focus?
A: Tomorrow Bio focuses on improving preservation quality and streamlining logistics to provide the best possible cryopreservation services.
Q: Who is Emil Kendziorra?
A: Emil Kendziorra is the CEO and Co-Founder of Tomorrow Bio, with a background in medicine and entrepreneurship.
Pro Tip: If you’re considering cryopreservation, thoroughly research different organizations and understand the associated risks and costs.
Want to learn more about the future of longevity and biostasis? Explore other articles on our site or visit Tomorrow Bio’s website.
